• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

犬黏液瘤性二尖瓣疾病的严重程度可通过中性粒细胞与淋巴细胞比值和单核细胞与淋巴细胞比值预测。

Severity of myxomatous mitral valve disease in dogs may be predicted using neutrophil-to-lymphocyte and monocyte-to-lymphocyte ratio.

机构信息

Laboratory of Veterinary Internal Medicine, College of Veterinary Medicine, Chungbuk National University, Cheongju, Chungbuk, South Korea.

Department of Veterinary Imaging, Veterinary Teaching Hospital, College of Veterinary Medicine, Chungbuk National University Cheongju, Chungbuk, South Korea.

出版信息

Am J Vet Res. 2023 Apr 10;84(6). doi: 10.2460/ajvr.23.01.0012. Print 2023 Jun 1.

DOI:10.2460/ajvr.23.01.0012
PMID:37024099
Abstract

OBJECTIVE

To investigate the neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR), and platelet-to-lymphocyte ratio (PLR) in dogs with myxomatous mitral valve disease (MMVD).

ANIMALS

106 dogs with MMVD and 22 healthy dogs were included in the study.

PROCEDURES

CBC data were obtained retrospectively, and NLR, MLR, and PLR were compared between dogs with MMVD and healthy dogs. The ratios were also analyzed according to MMVD severity.

RESULTS

NLR and MLR were significantly higher in dogs with MMVD C and D (NLR of 4.99 [3.69-7.27]; MLR of 0.56 [0.36-0.74]) than in healthy dogs (NLR: 3.05 [1.82-3.37], P < .001; MLR: 0.21 [0.14-0.32], P < .001), MMVD stage B1 (NLR: 3.15 [2.15-3.86], P < .001; MLR: 0.26 [0.20-0.36], P < .001), and MMVD stage B2 dogs (NLR: 3.22 [2.45-3.85], P < .001; MLR: 0.30 [0.19-0.37], P < .001). The area under the receiver operating characteristic curves of the NLR and MLR to distinguish dogs with MMVD C and D from those with MMVD B were 0.84 and 0.89, respectively. The optimal cutoff value for NLR was 4.296 (sensitivity, 68%; specificity, 83.95%), and the MLR value was 0.322 (sensitivity, 96%; specificity, 66.67%). NLR and MLR were significantly decreased after treatment in dogs with congestive heart failure (CHF).

CLINICAL RELEVANCE

NLR and MLR can be used as adjunctive indicators of CHF in dogs.

摘要

目的

研究中性粒细胞与淋巴细胞比值(NLR)、单核细胞与淋巴细胞比值(MLR)和血小板与淋巴细胞比值(PLR)在患有黏液样心肌二尖瓣病(MMVD)的犬中的变化。

动物

本研究纳入了 106 只 MMVD 犬和 22 只健康犬。

程序

回顾性获取全血细胞计数数据,并比较 MMVD 犬和健康犬之间的 NLR、MLR 和 PLR。还根据 MMVD 严重程度对比值进行了分析。

结果

MMVD C 和 D 级犬的 NLR 和 MLR 显著高于健康犬(NLR:4.99[3.69-7.27];MLR:0.56[0.36-0.74],P<0.001;NLR:3.05[1.82-3.37],P<0.001)、MMVD 阶段 B1 犬(NLR:3.15[2.15-3.86],P<0.001;MLR:0.26[0.20-0.36],P<0.001)和 MMVD 阶段 B2 犬(NLR:3.22[2.45-3.85],P<0.001;MLR:0.30[0.19-0.37],P<0.001)。NLR 和 MLR 区分 MMVD C 和 D 级犬与 MMVD B 级犬的受试者工作特征曲线下面积分别为 0.84 和 0.89。NLR 的最佳截断值为 4.296(敏感性,68%;特异性,83.95%),MLR 值为 0.322(敏感性,96%;特异性,66.67%)。充血性心力衰竭(CHF)犬治疗后 NLR 和 MLR 显著降低。

临床相关性

NLR 和 MLR 可作为犬 CHF 的辅助指标。

相似文献

1
Severity of myxomatous mitral valve disease in dogs may be predicted using neutrophil-to-lymphocyte and monocyte-to-lymphocyte ratio.犬黏液瘤性二尖瓣疾病的严重程度可通过中性粒细胞与淋巴细胞比值和单核细胞与淋巴细胞比值预测。
Am J Vet Res. 2023 Apr 10;84(6). doi: 10.2460/ajvr.23.01.0012. Print 2023 Jun 1.
2
Neutrophil-to-lymphocyte ratio is increased in dogs with acute congestive heart failure secondary to myxomatous mitral valve disease compared to both dogs with heart murmurs and healthy controls.与患有心脏杂音的犬只和健康对照相比,继发于黏液瘤性二尖瓣疾病的急性充血性心力衰竭犬的中性粒细胞与淋巴细胞比值升高。
J Am Vet Med Assoc. 2023 Jul 5;261(11):1-8. doi: 10.2460/javma.23.03.0131. Print 2023 Nov 1.
3
Prognostic Efficacy of Complete Blood Count Indices for Assessing the Presence and the Progression of Myxomatous Mitral Valve Disease in Dogs.全血细胞计数指标对评估犬黏液瘤性二尖瓣疾病的存在及进展的预后价值
Animals (Basel). 2023 Sep 5;13(18):2821. doi: 10.3390/ani13182821.
4
Retrospective evaluation of the utility of shock index to determine the presence of congestive heart failure in dogs with myxomatous mitral valve disease (2019-2021): 98 cases.回顾性评估休克指数在诊断黏液瘤性二尖瓣疾病犬充血性心力衰竭中的作用(2019-2021 年):98 例。
J Vet Emerg Crit Care (San Antonio). 2024 May-Jun;34(3):231-237. doi: 10.1111/vec.13379. Epub 2024 May 29.
5
Heart rate, heart rate variability, and arrhythmias in dogs with myxomatous mitral valve disease.患有黏液样二尖瓣疾病的犬的心率、心率变异性和心律失常。
J Vet Intern Med. 2012 Jan-Feb;26(1):76-84. doi: 10.1111/j.1939-1676.2011.00842.x. Epub 2011 Dec 13.
6
Left Atrial Strain at Different Stages of Myxomatous Mitral Valve Disease in Dogs.犬黏液瘤性二尖瓣疾病不同阶段的左心房应变
J Vet Intern Med. 2017 Mar;31(2):316-325. doi: 10.1111/jvim.14660. Epub 2017 Feb 1.
7
Diagnostic value of atrial natriuretic peptide (ANP), B-type natriuretic peptide (BNP) and their correlation with lipoproteins in dogs with myxomatous mitral valve disease.在患有黏液样二尖瓣疾病的犬中,心钠肽 (ANP)、B 型利钠肽 (BNP) 的诊断价值及其与脂蛋白的相关性。
BMC Vet Res. 2022 Dec 23;18(1):448. doi: 10.1186/s12917-022-03548-2.
8
Plasma and serum serotonin concentrations and surface-bound platelet serotonin expression in Cavalier King Charles Spaniels with myxomatous mitral valve disease.患有黏液瘤性二尖瓣疾病的查理士王小猎犬的血浆和血清5-羟色胺浓度以及表面结合血小板5-羟色胺表达
Am J Vet Res. 2015 Jun;76(6):520-31. doi: 10.2460/ajvr.76.6.520.
9
Efficacy of a mitral regurgitation severity index to predict long-term outcome in dogs with myxomatous mitral valve disease.二尖瓣反流严重指数对黏液样变性性二尖瓣疾病犬长期预后的预测效果。
J Vet Intern Med. 2024 Jan-Feb;38(1):51-60. doi: 10.1111/jvim.16923. Epub 2023 Nov 1.
10
Peripheral blood lymphocyte subtypes in dogs with different stages of myxomatous mitral valve disease.不同阶段黏液瘤性二尖瓣疾病犬的外周血淋巴细胞亚群。
J Vet Intern Med. 2021 Sep;35(5):2112-2122. doi: 10.1111/jvim.16207. Epub 2021 Jul 8.

引用本文的文献

1
Some Predictive Indexes Are Potentially Promising Clinical Parameters in Dogs with Primary Cholangitis-Cholangiohepatitis.一些预测指标可能是原发性胆管炎-胆管肝炎犬有前景的临床参数。
Vet Med Sci. 2025 Sep;11(5):e70559. doi: 10.1002/vms3.70559.
2
Involvement of TGF-β, mTOR, and inflammatory mediators in aging alterations during myxomatous mitral valve disease in a canine model.犬粘液瘤样二尖瓣疾病衰老改变中转化生长因子-β、雷帕霉素靶蛋白及炎症介质的作用
Geroscience. 2025 Jan 27. doi: 10.1007/s11357-025-01520-0.
3
Inflammatory and immune variables as predictors of survival in dogs with myxomatous mitral valve disease.
炎症和免疫变量作为预测黏液样二尖瓣疾病犬生存的指标。
BMC Vet Res. 2024 Sep 28;20(1):431. doi: 10.1186/s12917-024-04266-7.
4
Neutrophil-to-lymphocyte ratio and red blood cell distribution width to platelet ratio and their relationships with inflammatory and antioxidant status in dogs with different stages of heart failure due to myxomatous mitral valve disease.中性粒细胞与淋巴细胞比值及红细胞分布宽度与血小板比值及其与不同阶段黏液瘤性二尖瓣病致心力衰竭犬炎症和抗氧化状态的关系。
Vet Res Commun. 2024 Aug;48(4):2477-2487. doi: 10.1007/s11259-024-10431-y. Epub 2024 Jun 8.
5
Monocytes Count, NLR, MLR and PLR in Canine Inflammatory Bowel Disease.犬炎症性肠病中的单核细胞计数、中性粒细胞与淋巴细胞比值、单核细胞与淋巴细胞比值及血小板与淋巴细胞比值
Animals (Basel). 2024 Mar 8;14(6):837. doi: 10.3390/ani14060837.
6
Investigation of red blood cell and platelet indices in adult dogs suffered from myxomatous mitral valve disease with and without pulmonary hypertension.患有或未患有肺动脉高压的成年患黏液瘤性二尖瓣疾病犬的红细胞和血小板指数研究。
Front Vet Sci. 2023 Sep 15;10:1234768. doi: 10.3389/fvets.2023.1234768. eCollection 2023.
7
Prognostic Efficacy of Complete Blood Count Indices for Assessing the Presence and the Progression of Myxomatous Mitral Valve Disease in Dogs.全血细胞计数指标对评估犬黏液瘤性二尖瓣疾病的存在及进展的预后价值
Animals (Basel). 2023 Sep 5;13(18):2821. doi: 10.3390/ani13182821.